1673 related articles for article (PubMed ID: 16111817)
1. Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III).
Pérez-De La Cruz V; González-Cortés C; Galván-Arzate S; Medina-Campos ON; Pérez-Severiano F; Ali SF; Pedraza-Chaverrí J; Santamaría A
Neuroscience; 2005; 135(2):463-74. PubMed ID: 16111817
[TBL] [Abstract][Full Text] [Related]
2. Iron porphyrinate Fe(TPPS) reduces brain cell damage in rats intrastriatally lesioned by quinolinate.
González-Cortés C; Salinas-Lara C; Gómez-López MA; Tena-Suck ML; Pérez-De La Cruz V; Rembao-Bojórquez D; Pedraza-Chaverrí J; Gómez-Ruiz C; Galván-Arzate S; Ali SF; Santamaría A
Neurotoxicol Teratol; 2008; 30(6):510-9. PubMed ID: 18579343
[TBL] [Abstract][Full Text] [Related]
3. Targeting oxidative/nitrergic stress ameliorates motor impairment, and attenuates synaptic mitochondrial dysfunction and lipid peroxidation in two models of Huntington's disease.
Pérez-De La Cruz V; Elinos-Calderón D; Robledo-Arratia Y; Medina-Campos ON; Pedraza-Chaverrí J; Ali SF; Santamaría A
Behav Brain Res; 2009 May; 199(2):210-7. PubMed ID: 19100293
[TBL] [Abstract][Full Text] [Related]
4. NAD(P)H oxidase contributes to neurotoxicity in an excitotoxic/prooxidant model of Huntington's disease in rats: protective role of apocynin.
Maldonado PD; Molina-Jijón E; Villeda-Hernández J; Galván-Arzate S; Santamaría A; Pedraza-Chaverrí J
J Neurosci Res; 2010 Feb; 88(3):620-9. PubMed ID: 19795371
[TBL] [Abstract][Full Text] [Related]
5. Contribution of nitric oxide, superoxide anion, and peroxynitrite to activation of mitochondrial apoptotic signaling in hippocampal CA3 subfield following experimental temporal lobe status epilepticus.
Chuang YC; Chen SD; Liou CW; Lin TK; Chang WN; Chan SH; Chang AY
Epilepsia; 2009 Apr; 50(4):731-46. PubMed ID: 19178557
[TBL] [Abstract][Full Text] [Related]
6. S-Allylcysteine, a garlic-derived antioxidant, ameliorates quinolinic acid-induced neurotoxicity and oxidative damage in rats.
Pérez-Severiano F; Rodríguez-Pérez M; Pedraza-Chaverrí J; Maldonado PD; Medina-Campos ON; Ortíz-Plata A; Sánchez-García A; Villeda-Hernández J; Galván-Arzate S; Aguilera P; Santamaría A
Neurochem Int; 2004 Dec; 45(8):1175-83. PubMed ID: 15380627
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide.
Kumar P; Kumar A
Behav Brain Res; 2010 Jan; 206(1):38-46. PubMed ID: 19716383
[TBL] [Abstract][Full Text] [Related]
8. Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington's disease.
Ryu JK; Kim SU; McLarnon JG
Exp Neurol; 2004 May; 187(1):150-9. PubMed ID: 15081596
[TBL] [Abstract][Full Text] [Related]
9. Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine.
Silva-Adaya D; Pérez-De La Cruz V; Herrera-Mundo MN; Mendoza-Macedo K; Villeda-Hernández J; Binienda Z; Ali SF; Santamaría A
J Neurochem; 2008 May; 105(3):677-89. PubMed ID: 18194214
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effect of MK-801 against intra-striatal quinolinic acid induced behavioral, oxidative stress and cellular alterations in rats.
Kalonia H; Kumar P; Nehru B; Kumar A
Indian J Exp Biol; 2009 Nov; 47(11):880-92. PubMed ID: 20099461
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic calcium mediates oxidative damage in an excitotoxic /energetic deficit synergic model in rats.
Pérez-De La Cruz V; Konigsberg M; Pedraza-Chaverri J; Herrera-Mundo N; Díaz-Muñoz M; Morán J; Fortoul-van der Goes T; Rondán-Zárate A; Maldonado PD; Ali SF; Santamaría A
Eur J Neurosci; 2008 Mar; 27(5):1075-85. PubMed ID: 18364032
[TBL] [Abstract][Full Text] [Related]
12. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
Kumar P; Kumar A
Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928
[TBL] [Abstract][Full Text] [Related]
14. Comparative neuroprotective profile of statins in quinolinic acid induced neurotoxicity in rats.
Kalonia H; Kumar P; Kumar A
Behav Brain Res; 2011 Jan; 216(1):220-8. PubMed ID: 20696189
[TBL] [Abstract][Full Text] [Related]
15. Selenium reduces the proapoptotic signaling associated to NF-kappaB pathway and stimulates glutathione peroxidase activity during excitotoxic damage produced by quinolinate in rat corpus striatum.
Santamaría A; Vázquez-Román B; La Cruz VP; González-Cortés C; Trejo-Solís MC; Galván-Arzate S; Jara-Prado A; Guevara-Fonseca J; Ali SF
Synapse; 2005 Dec; 58(4):258-66. PubMed ID: 16206188
[TBL] [Abstract][Full Text] [Related]
16. Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats.
Dhir A; Akula KK; Kulkarni SK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):835-43. PubMed ID: 18234412
[TBL] [Abstract][Full Text] [Related]
17. Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease.
Scattoni ML; Valanzano A; Pezzola A; March ZD; Fusco FR; Popoli P; Calamandrei G
Behav Brain Res; 2007 Jan; 176(2):216-21. PubMed ID: 17123640
[TBL] [Abstract][Full Text] [Related]
18. Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington's disease.
Ryu JK; Choi HB; McLarnon JG
Neuroscience; 2006 Sep; 141(4):1835-48. PubMed ID: 16809003
[TBL] [Abstract][Full Text] [Related]
19. Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro.
Colle D; Hartwig JM; Soares FA; Farina M
Brain Res Bull; 2012 Mar; 87(4-5):397-405. PubMed ID: 22245028
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of proinflammatory cytokines and apoptotic process by verapamil and diltiazem against quinolinic acid induced Huntington like alterations in rats.
Kalonia H; Kumar P; Kumar A
Brain Res; 2011 Feb; 1372():115-26. PubMed ID: 21112316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
